Investment Summary |
|
|---|---|
| Date | 2021-03-18 |
| Target | Magritek |
| Sector | Medical Products |
| Investor(s) | Ampersand Capital Partners |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 60 of 86 |
| Sector: Medical Products M&A | 15 of 18 |
| Type: Growth Capital M&A Deals | 17 of 25 |
| Country: New Zealand M&A | 1 of 2 |
| Year: 2021 M&A | 4 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-08 |
ANI Pharmaceuticals
Baudette, Minnesota, United States ANI Pharmaceuticals is a developer, manufacturer, and marketer of top-quality prescription pharmaceuticals. In two facilities with combined manufacturing, packaging, and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder, and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. ANI Pharmaceuticals was formed in 2001 and is based in Baudette, Minnesota. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-12 |
Nexcelom Bioscience
Lawrence, Massachusetts, United States Nexcelom Bioscience is a designer, manufacturer, and marketer of innovative Cellometer and Celigo image cytometry products designed for cell analysis in life science and biomedical research. Nexcelom Bioscience was founded in 2003 and is based in Lawrence, Massachusetts. |
Sell | $260M |
